Angiopoietin-like protein 4 and cardiovascular function in COPD

Area of Science:

• Cardiology
• Pulmonology
• Biomarker Discovery

Background:

• Chronic obstructive pulmonary disease (COPD) frequently coexists with cardiovascular disease (CVD).
• Inflammation may link COPD and CVD, with specific markers reflecting this relationship.
• Angiopoietin-like protein 4 (ANGPTL4) is an emerging cardiovascular marker.

Purpose of the Study:

• To investigate serum ANGPTL4 levels in stable COPD patients.
• To assess the relationship between ANGPTL4 and cardiovascular function in COPD.
• To explore ANGPTL4 as a potential biomarker for the COPD-CVD link.

Main Methods:

• Prospective cohort study of stable COPD patients and controls.
• Measured serum ANGPTL4, ankle-brachial index (ABI), N-terminal pro-B-type natriuretic peptide (NT-proBNP), hs-CRP, and other CVD risk factors.
• Internal validation using a larger COPD cohort and echocardiography.

Main Results:

• ANGPTL4 levels were significantly higher in COPD patients versus controls.
• Higher ANGPTL4 was independently associated with lower ABI and higher NT-proBNP, even after adjusting for traditional CVD risk factors.
• Findings were confirmed in validation analyses.

Conclusions:

• Serum ANGPTL4 is independently associated with cardiovascular function in COPD patients.
• ANGPTL4 may serve as a biomarker indicating a pathogenic link between COPD and CVD.